- Home
- CHRS vs CHGG Comparison
CHRS vs CHGG Comparison
Compare CHRS & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRS | CHGG |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.5M | 63.6M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CHRS | CHGG |
|---|---|---|
| Price | $1.67 | $0.63 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | ★ $5.51 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 665.5K |
| Earning Date | 03-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 472.00 | 88.15 |
| EPS | ★ 1.43 | N/A |
| Revenue | N/A | ★ $376,908,000.00 |
| Revenue This Year | $73.08 | N/A |
| Revenue Next Year | $30.94 | N/A |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.44 |
| 52 Week High | $2.62 | $1.89 |
Technical Indicators
Market Signals| Indicator | CHRS | CHGG |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 58.44 |
| Support Level | $1.55 | $0.53 |
| Resistance Level | $1.75 | $0.68 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 26.04 | 93.90 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.